Trials / Completed
CompletedNCT00679107
A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions
A Prospective, Randomized, Controlled, Multicenter, Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Olympus Biotech Corporation · Industry
- Sex
- All
- Age
- 18 Years – 81 Years
- Healthy volunteers
- Not accepted
Summary
This study will explore the use of OP-1 Putty in conjunction with surgical treatment for the treatment of spinal decompression and lumbar spinal fusion.
Detailed description
It is postulated that the addition of OP-1 Putty to autogenous bone will prove beneficial in the treatment of patients requiring decompression and lumbar spinal fusion. The Investigational system is intended to stimulate bone growth. It is indicated as an adjunct or a replacement for autograft in spinal fusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of OP-1 Putty in Uninstrumented posterolateral fusion | Use of OP-1 Putty in Uninstrumented posterolateral fusion |
Timeline
- Start date
- 1999-06-01
- Primary completion
- 2000-12-01
- Completion
- 2005-07-01
- First posted
- 2008-05-16
- Last updated
- 2011-06-10
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00679107. Inclusion in this directory is not an endorsement.